A Study of the Outcomes of Abdominal Pelvic Organ Prolapse Repair and the Introduction of the Enhanced Recovery Protocol

Overview

About this study

The purpose of this study is to compare pre and post-operative outcomes of undergoing open repair for pelvic organ prolapse with or without Enhanced Recovery Protocol , or also with the addition of liposomal Bupivacine, or compared to undergoing the procedure performed robotically.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Females 
  • Older than 21 years of age
  • Had symptomatic stage 2 anterior or apical prolapse (points Ba or C > -1 cm)  
  • Underwent an open or robotic sacrocolpopexy (prolapse repair) during the specified time periods
  • Has given permission to participate in clinical research 
  • A concomitant hysterectomy during the index procedure will not  be excluded

Exclusion Criteria

  • Had a concomitant Pouch of Douglas hernia repair
  • Had a prior vaginal mesh kits repair or needed concomitant mesh removal
  • Had a history of radical pelvic surgery or class 3 obesity

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Emanuel Trabuco, M.D.

Closed for enrollment

Contact information:

Emanuel Trabuco M.D.

(507) 538-8400

Trabuco.Emanuel@mayo.edu

More information

Publications

Publications are currently not available